Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Ho Song

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Optics Express|June 30, 2019
One-dimensional surface wrinkling for twisted nematic liquid crystal display based on ultraviolet nanoimprint lithographyHae-Chang Jeong, Ju Hwan Lee, Jonghoon Won, et al.
Cancers|October 13, 2021
Effect of Peptide Receptor Radionuclide Therapy in Combination with Temozolomide against Tumor Angiogenesis in a Glioblastoma ModelSang Hee Lee, Ji Young Choi, Jae Ho Jung, et al.
Rheumatology (Oxford, England)|August 21, 2014
Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
Environmental Science & Technology|May 27, 2021
Particulate Nitrosamines and Nitramines in Seoul and Their Major Sources: Primary Emission versus Secondary FormationNa Rae Choi, Yun Gyong Ahn, Ji Yi Lee, et al.
Rheumatology (Oxford, England)|October 20, 2021
A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibitionIain B McInnes, Zoltán Szekanecz, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trialIn-Ho Song, Anja Weiß, Kay-Geert A Hermann, et al.
Arthritis Research & Therapy|September 18, 2023
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III studyXenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, et al.
International Journal of Molecular Sciences|February 10, 2024
Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and ImagingHwa Yeon Jeong, Seong Jae Kang, Min Woo Kim, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 27, 2012
Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferaseJae-Jun Park, Tae-Sup Lee, Jin-Ju Son, et al.
Rheumatology (Oxford, England)|December 13, 2021
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 programCharles G Peterfy, Vibeke Strand, Alan Friedman, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Optics Express|June 30, 2019
One-dimensional surface wrinkling for twisted nematic liquid crystal display based on ultraviolet nanoimprint lithographyHae-Chang Jeong, Ju Hwan Lee, Jonghoon Won, et al.
Cancers|October 13, 2021
Effect of Peptide Receptor Radionuclide Therapy in Combination with Temozolomide against Tumor Angiogenesis in a Glioblastoma ModelSang Hee Lee, Ji Young Choi, Jae Ho Jung, et al.
Rheumatology (Oxford, England)|August 21, 2014
Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.
Environmental Science & Technology|May 27, 2021
Particulate Nitrosamines and Nitramines in Seoul and Their Major Sources: Primary Emission versus Secondary FormationNa Rae Choi, Yun Gyong Ahn, Ji Yi Lee, et al.
Rheumatology (Oxford, England)|October 20, 2021
A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibitionIain B McInnes, Zoltán Szekanecz, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trialIn-Ho Song, Anja Weiß, Kay-Geert A Hermann, et al.
Arthritis Research & Therapy|September 18, 2023
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III studyXenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, et al.
International Journal of Molecular Sciences|February 10, 2024
Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and ImagingHwa Yeon Jeong, Seong Jae Kang, Min Woo Kim, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 27, 2012
Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferaseJae-Jun Park, Tae-Sup Lee, Jin-Ju Son, et al.
Rheumatology (Oxford, England)|December 13, 2021
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 programCharles G Peterfy, Vibeke Strand, Alan Friedman, et al.
Pageof 11